Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

January 1, 2023; Volume 64,Issue 1

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 8A;

Editor’s Page

  • You have access
    Thank You Drs. Ziessman and Knight for Your Many Years of Newsline Coverage
    Johannes Czernin
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 1;

Highlights

  • You have access
    2022 SNMMI Highlights Lecture: Oncology and Therapy, Part 2
    Heiko Schöder
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 2-7; DOI: https://doi.org/10.2967/jnumed.122.265202

Discussions with Leaders

  • You have access
    From Physician to Leader in Global Research and Development
    Ken Song, Lisa Bodei and Johannes Czernin
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 8-11; DOI: https://doi.org/10.2967/jnumed.122.265135

The State of the Art

  • You have access
    Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders
    John P. Seibyl
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 12-19; DOI: https://doi.org/10.2967/jnumed.122.264773

Continuing Education

  • You have access
    Brain Trauma Imaging
    Gérard N. Bischof and Donna J. Cross
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 20-29; DOI: https://doi.org/10.2967/jnumed.121.263293

Focus on Molecular Imaging

  • Open Access
    Imaging of Activated T Cells
    Mohammad O. Sako and Benjamin M. Larimer
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 30-33; DOI: https://doi.org/10.2967/jnumed.122.264097

Theranostics

  • Clinical

    • FEATURED ARTICLE OF THE MONTH

      • C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
        You have access
        C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
        Andreas K. Buck, Götz Ulrich Grigoleit, Sabrina Kraus, Andreas Schirbel, Michael Heinsch, Niklas Dreher, Takahiro Higuchi, Constantin Lapa, Heribert Hänscheid, Samuel Samnick, Hermann Einsele, Sebastian E. Serfling and Rudolf A. Werner
        Journal of Nuclear Medicine January 1, 2023, 64 (1) 34-39; DOI: https://doi.org/10.2967/jnumed.122.264207
    • Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients
      You have access
      Long-Term Outcomes of Submaximal Activities of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients
      Noémie S. Minczeles, Wouter W. de Herder, Richard A. Feelders, Frederik A. Verburg, Johannes Hofland and Tessa Brabander
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 40-46; DOI: https://doi.org/10.2967/jnumed.122.263856
    • A 2022 International Survey on the Status of Prostate Cancer Theranostics
      You have access
      A 2022 International Survey on the Status of Prostate Cancer Theranostics
      Thomas Beyer, Johannes Czernin, Lutz Freudenberg, Frederik Giesel, Marcus Hacker, Rodney J. Hicks and Bernd J. Krause
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 47-53; DOI: https://doi.org/10.2967/jnumed.122.264298
    • BRIEF COMMUNICATION

      • You have access
        177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
        Thorsten Derlin, Liam Widjaja, Rudolf A. Werner and Frank M. Bengel
        Journal of Nuclear Medicine January 1, 2023, 64 (1) 54-58; DOI: https://doi.org/10.2967/jnumed.122.264293
    • BRIEF COMMUNICATION

      • Feasibility of <sup>99m</sup>Tc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
        You have access
        Feasibility of 99mTc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
        Daniel Koehler, Markus Sauer, Susanne Klutmann, Ivayla Apostolova, Wencke Lehnert, Lars Budäus, Sophie Knipper and Tobias Maurer
        Journal of Nuclear Medicine January 1, 2023, 64 (1) 59-62; DOI: https://doi.org/10.2967/jnumed.122.263892
    • The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on <sup>68</sup>Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer
      You have access
      The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer
      Hinke Siebinga, Judith olde Heuvel, Erik-Jan Rijkhorst, Jeroen J.M.A. Hendrikx and Berlinda J. de Wit-van der Veen
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 63-68; DOI: https://doi.org/10.2967/jnumed.122.264101
  • Basic

    • The Prognostic Value of Posttreatment <sup>68</sup>Ga-PSMA-11 PET/CT and <sup>18</sup>F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with <sup>177</sup>Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN)
      You have access
      The Prognostic Value of Posttreatment 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617 and NOX66 in a Phase I/II Trial (LuPIN)
      Sarennya Pathmanandavel, Megan Crumbaker, Andrew Nguyen, Andrew O. Yam, Peter Wilson, Remy Niman, Maria Ayers, Shikha Sharma, Peter Eu, Andrew J. Martin, Martin R. Stockler, Anthony M. Joshua and Louise Emmett
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 69-74; DOI: https://doi.org/10.2967/jnumed.122.264104

Oncology

  • Clinical

    • Lack of Adherence to Guideline-Based Imaging Before Subsequent Radiation in Patients with Non–Small Cell Lung Cancer: Impact on Patient Outcomes
      You have access
      Lack of Adherence to Guideline-Based Imaging Before Subsequent Radiation in Patients with Non–Small Cell Lung Cancer: Impact on Patient Outcomes
      Emily Sterbis, Rifei Liang, Premal Trivedi, Jennifer Kwak, Erica Cohen Major, Sana D. Karam and Rustain L. Morgan
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 75-81; DOI: https://doi.org/10.2967/jnumed.122.264131
    • Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study
      You have access
      Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study
      Babs G. Sibinga Mulder, Marjory Koller, Evelien W. Duiker, Arantza Farina Sarasqueta, Jakobus Burggraaf, Vincent E. de Meijer, Alexander L. Vahrmeijer, Frederik J.H. Hoogwater, Bert A. Bonsing, Gooitzen M. van Dam, J. Sven D. Mieog and Bobby K. Pranger
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 82-89; DOI: https://doi.org/10.2967/jnumed.121.263773
    • Diagnostic Accuracy of <sup>99m</sup>Tc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses
      You have access
      Diagnostic Accuracy of 99mTc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses
      Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa R. Schmidt, Robert S. Figenshau, Farrokh Dehdashti and Richard L. Wahl
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 90-95; DOI: https://doi.org/10.2967/jnumed.122.264329
    • Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients
      You have access
      Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients
      Thomas W. Georgi, Dietrich Stoevesandt, Lars Kurch, Jörg M. Bartelt, Dirk Hasenclever, Helmut Dittmann, Jiri Ferda, Peter Francis, Christiane Franzius, Christian Furth, Daniel Gräfe, Alexander Gussew, Martin Hüllner, Leon J. Menezes, Mona Mustafa, Lars Stegger, Lale Umutlu, Klaus Zöphel, Pietro Zucchetta, Dieter Körholz, Osama Sabri, Christine Mauz-Körholz and Regine Kluge
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 96-101; DOI: https://doi.org/10.2967/jnumed.122.264112
    • Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1—Clinical)
      You have access
      Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1—Clinical)
      Fabien Ricard, Bruce Cheson, Sally Barrington, Judith Trotman, Annette Schmid, Guenther Brueggenwerth, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Jayant Narang, Florence Broussais, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann and Ron Korn
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 102-108; DOI: https://doi.org/10.2967/jnumed.122.264106
  • Basic

    • Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using <sup>213</sup>Bi-Anti-CD20 Monoclonal Antibody
      Open Access
      Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using 213Bi-Anti-CD20 Monoclonal Antibody
      Gregory T. Havlena, Nirav S. Kapadia, Peng Huang, Hong Song, James Engles, Martin Brechbiel, George Sgouros and Richard L. Wahl
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 109-116; DOI: https://doi.org/10.2967/jnumed.122.263962
    • <sup>18</sup>F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
      You have access
      18F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
      Thuc M. Le, Hailey R. Lee, Evan R. Abt, Khalid Rashid, Amanda L. Creech, Keke Liang, Jing Cui, Arthur Cho, Liu Wei, Amanda Labora, Charlotte Chan, Eric Sanchez, Kriti Kriti, Daniel Karin, Luyi Li, Nanping Wu, Christine Mona, Giuseppe Carlucci, Willy Hugo, Ting-Ting Wu, Timothy R. Donahue, Johannes Czernin and Caius G. Radu
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 117-123; DOI: https://doi.org/10.2967/jnumed.122.264121
    • Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose <sup>211</sup>At-Labeled Anti-HER2 Single-Domain Antibody Fragment
      You have access
      Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment
      Yutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, Stephen Jannetti, Ganesan Vaidyanathan and Michael R. Zalutsky
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 124-130; DOI: https://doi.org/10.2967/jnumed.122.264071
    • <sup>18</sup>F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models
      You have access
      18F-Fluciclovine PET Imaging of Glutaminase Inhibition in Breast Cancer Models
      Rong Zhou, Hoon Choi, Jianbo Cao, Austin Pantel, Mamta Gupta, Hsiaoju S. Lee and David Mankoff
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 131-136; DOI: https://doi.org/10.2967/jnumed.122.264152
    • FEATURED BASIC SCIENCE ARTICLE

      • Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma
        Open Access
        Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma
        Jaehoon Shin, Matthew F.L. Parker, Iowis Zhu, Aryn Alanizi, Carlos I. Rodriguez, Raymond Liu, Payal B. Watchmaker, Mausam Kalita, Joseph Blecha, Justin Luu, Brian Wright, Suzanne E. Lapi, Robert R. Flavell, Hideho Okada, Thea D. Tlsty, Kole T. Roybal and David M. Wilson
        Journal of Nuclear Medicine January 1, 2023, 64 (1) 137-144; DOI: https://doi.org/10.2967/jnumed.122.264284

Covid Commentaries

  • Clinical

    • BRIEF COMMUNICATION

      • In Vivo Visualization and Quantification of Neutrophil Elastase in Lungs of COVID-19 Patients: A First-in-Humans PET Study with <sup>11</sup>C-NES
        Open Access
        In Vivo Visualization and Quantification of Neutrophil Elastase in Lungs of COVID-19 Patients: A First-in-Humans PET Study with 11C-NES
        Gunnar Antoni, Mark Lubberink, Jens Sörensen, Elin Lindström, Mathias Elgland, Olof Eriksson, Michael Hultström, Robert Frithiof, Anders Wanhainen, Jonathan Sigfridsson, Paul Skorup and Miklos Lipcsey
        Journal of Nuclear Medicine January 1, 2023, 64 (1) 145-148; DOI: https://doi.org/10.2967/jnumed.122.263974

Cardiovascular

  • Clinical

    • SPECIAL CONTRIBUTION

      • Open Access
        SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association
        Terrence D. Ruddy, Mouaz Al-Mallah, James A. Arrighi, John P. Bois, David A. Bluemke, Marcelo F. Di Carli, Vasken Dilsizian, Robert J. Gropler, Hossein Jadvar, Saurabh Malhotra, Matthieu Pelletier-Galarneau, Thomas H. Schindler, Pamela K. Woodard and Panithaya Chareonthaitawee
        Journal of Nuclear Medicine January 1, 2023, 64 (1) 149-152; DOI: https://doi.org/10.2967/jnumed.122.264200

Neurology

  • Clinical

    • High-Resolution Silicon Photomultiplier Time-of-Flight Dedicated Head PET System for Clinical Brain Studies
      Open Access
      High-Resolution Silicon Photomultiplier Time-of-Flight Dedicated Head PET System for Clinical Brain Studies
      Kazunari Ishii, Kohei Hanaoka, Shota Watanabe, Daisuke Morimoto-Ishikawa, Takahiro Yamada, Hayato Kaida, Yoshiyuki Yamakawa, Suzuka Minagawa, Shiho Takenouchi, Atsushi Ohtani and Tetsuro Mizuta
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 153-158; DOI: https://doi.org/10.2967/jnumed.122.264080

Inflammation/Infection

  • Clinical

    • Whole-Body PET Imaging in Humans Shows That <sup>11</sup>C-PS13 Is Selective for Cyclooxygenase-1 and Can Measure the In Vivo Potency of Nonsteroidal Antiinflammatory Drugs
      You have access
      Whole-Body PET Imaging in Humans Shows That 11C-PS13 Is Selective for Cyclooxygenase-1 and Can Measure the In Vivo Potency of Nonsteroidal Antiinflammatory Drugs
      Min-Jeong Kim, Fernanda Juarez Anaya, Lester S. Manly, Jae-Hoon Lee, Jinsoo Hong, Stal Shrestha, Sanjay Telu, Katharine Henry, Jose A. Montero Santamaria, Jeih-San Liow, Paolo Zanotti-Fregonara, H. Umesha Shetty, Sami S. Zoghbi, Victor W. Pike and Robert B. Innis
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 159-164; DOI: https://doi.org/10.2967/jnumed.122.264061

Radiobiology/Dosimetry

  • Clinical

    • Estimating the Risk for Secondary Cancer After Targeted α-Therapy with <sup>211</sup>At Intraperitoneal Radioimmunotherapy
      Open Access
      Estimating the Risk for Secondary Cancer After Targeted α-Therapy with 211At Intraperitoneal Radioimmunotherapy
      Erik Leidermark, Andreas Hallqvist, Lars Jacobsson, Per Karlsson, Erik Holmberg, Tom Bäck, Mia Johansson, Sture Lindegren, Stig Palm and Per Albertsson
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 165-172; DOI: https://doi.org/10.2967/jnumed.121.263349

Radiochemsitry/Radiopharmaceuticals

  • Basic

    • BRIEF COMMUNICATION

      • An Experimental Generator for Production of High-Purity <sup>212</sup>Pb for Use in Radiopharmaceuticals
        Open Access
        An Experimental Generator for Production of High-Purity 212Pb for Use in Radiopharmaceuticals
        Ruth Gong Li, Vilde Yuli Stenberg and Roy Hartvig Larsen
        Journal of Nuclear Medicine January 1, 2023, 64 (1) 173-176; DOI: https://doi.org/10.2967/jnumed.122.264009

Molecular Imaging

  • Basic

    • Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes
      You have access
      Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes
      Benedict E. Mc Larney, Qize Zhang, Edwin C. Pratt, Magdalena Skubal, Elizabeth Isaac, Hsiao-Ting Hsu, Anuja Ogirala and Jan Grimm
      Journal of Nuclear Medicine January 1, 2023, 64 (1) 177-182; DOI: https://doi.org/10.2967/jnumed.122.264079

Letters To The Editor

  • You have access
    What Does an Imaging “Selection” Claim Actually Mean?
    Rafel Dwaine Rieves
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 183; DOI: https://doi.org/10.2967/jnumed.122.264567
  • You have access
    Reply: What Does an Imaging “Selection” Claim Actually Mean?
    Phillip H. Kuo
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 183-184; DOI: https://doi.org/10.2967/jnumed.122.264835

Departments

  • You have access
    Recruitment
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 2A;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 64 (1)
Journal of Nuclear Medicine
Vol. 64, Issue 1
January 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma
  • Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma
Sign up for alerts

Jump to

  • This Month in JNM
  • Editor’s Page
  • Highlights
  • Discussions with Leaders
  • The State of the Art
  • Continuing Education
  • Focus on Molecular Imaging
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
      • BRIEF COMMUNICATION
      • BRIEF COMMUNICATION
    • Basic
  • Oncology
    • Clinical
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Covid Commentaries
    • Clinical
      • BRIEF COMMUNICATION
  • Cardiovascular
    • Clinical
      • SPECIAL CONTRIBUTION
  • Neurology
    • Clinical
  • Inflammation/Infection
    • Clinical
  • Radiobiology/Dosimetry
    • Clinical
  • Radiochemsitry/Radiopharmaceuticals
    • Basic
      • BRIEF COMMUNICATION
  • Molecular Imaging
    • Basic
  • Letters To The Editor
  • Departments
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire